What are you looking for? Write the name, title or any keyword related to what you are looking for and select which content category it belongs to. Search Fulltext search Activities Professionals Research groups News - Any - News A new project seeks to extend nucleoside therapy to different mitochondrial disorders CIBERER and CIBEREHD will study the possible extension of therapy based on the administration of deoxyribonucleosides to other disorders characterized by problems in the replication of mitochondrial DNA. News Vall d'Hebron advances in the knowledge of the biological causes of Dent's disease The CIBBIM-Nanomedicine-Renal Pathophysiology group of the VHIR has developed renal cell models to investigate the pathophysiological mechanisms and help provide new drugs for the treatment of this disease. News Vall d’Hebron, UAB and UPC design an app to help assess the severity of symptoms in chronic fatigue syndrome Researchers have shown that heart rate variability is related to the severity of fatigue in women with chronic fatigue syndrome / myalgic encephalomyelitis. News Vall d’Hebron participa en la creació d’un nou sistema per identificar nòduls indicadors de possibles càncers pulmonars amb Intel·ligència Artificial Aquesta eina ha estat desenvolupada per Eurecat amb la col.laboració del Campus Vall d'Hebron coordinada pel Servei de Diagnòstic per la Imatge de l'Hospital, en el marc del projecte Deep Lung. News Mutua Madrileña Foundation grants two Vall d'Hebron projects Dr. Javier Torres and Dr. Alberto Sandiumenge lead the selected works in the field of rare diseases and transplantation. News Two VHIR researchers have received awards at the Catalan Health Institute's 2021 Research Awards Vall d’Hebron University Hospital hosted the Catalan Institute of Health's (ICS) Research Conference earlier today, where the 2020 and 2021 ICS Research Awards were presented. News Kevin Arias is awarded at the X UAB Doctoral Workshop for the invention of a simpler malaria detection device The new device, much simpler and more immediate than current techniques, would generate results in 20 minutes and detect malaria in the most remote regions of the planet. News Vall d'Hebron demonstrates that the gut microbiota can facilitate the diagnosis of Crohn's disease and ulcerative colitis The quantification of the gut microbiota, combined with clinical data, would be useful to facilitate the correct diagnosis of patients and offer them the appropriate treatment for their pathology and also to prevent the appearance of flares. News Vall d'Hebron demonstrates that the gut microbiota can facilitate the diagnosis of Crohn's disease and ulcerative colitis The quantification of the gut microbiota, combined with clinical data, would be useful to facilitate the correct diagnosis of patients and offer them the appropriate treatment for their pathology and also to prevent the appearance of flares. News Researcher Alba Torija, awarded for the best oral communication for the analysis of the cells involved in the rejection of solid organs The advances, led by the VHIR Nephrology group, have been presented at the XVI Congress of the Catalan Transplantation Society. News Vall d'Hebron and IDIAP Jordi Gol collaborate in pediatric research in primary care The joint work has received a runner-up prize for the best Oral Communication from the Catalan Pediatric Society. News Endolipid Therapeutics, the spin-off of Vall d’Hebron and GENESIS Ventures, emerges to develop a new strategy to reduce visceral and subcutaneous fat Endolipid Therapeutics has developed a new approach to reducing visceral fat with therapeutic applications to treat, for example, fatty liver, and applications will be developed to reduce subcutaneous fat. News Vall d'Hebron participa un any més a la Festa de la Ciència La Festa de la Ciència tancarà aquest diumenge la Biennal Ciutat i Ciència 2021 amb un ventall d'activitats per apropar la ciència a la ciutadania. Professionals de Vall d'Hebron reflexionaran sobre telemedicina, intel.ligència artificial i càncer, i mutacions. News Five VHIR research projects on COVID-19 are promoted by La Marató 2020 Vall d'Hebron is the center with the most promoted projects from La Marató 2020 to research on COVID-19. Five out of the six projects are coordinated by VHIR researchers. News Vall d’Hebron assumes the rotating presidency of the European University Hospital Alliance (EUHA) Dr. Albert Salazar, manager of Vall d'Hebron University Hospital, assumes for the next six months the presidency of the European University Hospital Alliance (EUHA), an alliance formed by the largest university hospitals in Europe working in collaboration to improve the outcomes of patients from tod News The solidarity race "Km Contra El Cáncer Infantil" raises €15,000 for research on childhood cancer in Vall d’Hebron The proceeds will go to the study of liquid biopsy for the early detection of relapses in osteosarcoma, a project of the Translational Research Group in Child and Adolescent Cancer at VHIR. News A work led by Vall d'Hebron demonstrates the relationship between immune-mediated inflammatory diseases and changes in diet The study, carried out with more than 11,000 patients, aims to understand the effect of food on these diseases to give recommendations based on evidence. News Vall d'Hebron participates in the definition of microRNA profile as a biomarker to predict progression of COVID-19 in severe patients Thanks to this finding, we may be able to predict severity in patients affected by SARS-CoV-2 and prevent its progression. News Vall d’Hebron collaborates in the development of a novel nano-encapsulation approach for efficient dopamine delivery in Parkinson’s treatment In a study just published in the American Chemical Society's Journal "ACS Nano", polymeric nanoparticles inspired by natural neuromelanin were used to encapsulate dopamine and to be administered via intranasal to reach the brain for Parkinson's disease treatment. The effectiveness of this technique News Vall d’Hebron begins the clinical trial in pregnant women of the Pfizer-BioNTech vaccine against COVID-19 The clinical trial of the Pfizer-BioNTech vaccine in healthy pregnant women has begun today and the recruitment of volunteers to participate is underway. Pagination First page « Previous page ‹ … Page 55 Page 56 Current page 57 Page 58 Page 59 … Next page › Last page »
